Further to the announcement on 29 June 2018, Dr. Adrian Potts has commenced his role as Chief Executive Officer of the Company with effect from today, 1 August 2018. Accordingly, Jon Mabbitt has stepped down from the Board and, as previously announced, will continue in a part time advisory role to support the further development of the Company.
Dr. Bryan Dobson, Non-Executive Chairman of AGM, commented:
“I would like to welcome Adrian to the Board of AGM and look forward to working with him in the next phase of AGM’s evolution.
I would also like to take this opportunity to thank Jon for his major contribution to the development of AGM. As CEO he has led the Company from a start-up to an established organisation set to play a key role in the use of graphene in major industrial applications.”
Regulatory disclosures
In accordance with Schedule 2(g) of the AIM Rules, Dr. Hugh Adrian Potts (aged 57) holds or has held the following directorships and partnerships:
Current |
Past five years |
None |
Cytec Process Materials Inc |
|
|
Adrian Potts holds 18,109 ordinary shares in the Company.
Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.